Azienda Ospedaliera Universitaria Policlinico Umberto I

Roma 00161

0 studies enrolling now · 3 studies all time

What they study most

Complete Response, Epithelial Ovarian Cancer, FIGO Stage III-IV, Fallopian Tube Cancer, Newly Diagnosed, Osteogenesis Imperfecta, Partial Response, Post-essential Thrombocythemia Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Primary Myelofibrosis, Primary Peritoneal

Studies at this site

• Setrusumab vs Bisphosphonates in Pediatric Subjects With Osteogenesis Imperfecta — Running, not enrolling
• A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy — Running, not enrolling
• Study to Assess Efficacy and Safety of NS-018 Compared to BAT in Patients With Myelofibrosis — Stopped early